Accelerating innovation in immunology

ASLAN Pharmaceuticals is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients

Learn More

News

Read about our latest product developments and partnerships, industry advances and events.

View All News
Eblasakimab, Translational work | May 21, 2024

Eblasakimab Significantly Alleviates IL-4 and IL-13-Induced Bronchial Airway Constriction in COPD-Derived Lung Slices

Ferda Cevikbas, Paul E Miller, Carl Firth
Eblasakimab Significantly Alleviates IL-4 and IL-13-Induced Bronchial Airway Constriction in COPD-Derived Lung Slices
Clinical publications, Eblasakimab | February 22, 2024

Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose study

Karen A. Veverka, Steven T.G. Thng, Jonathan I. Silverberg, April W. Armstrong, Josemund Menezes, Alexandre Kaoukhov, Andrew Blauvelt
Veverka et al JAAD publication, October 2023
Eblasakimab, Translational work | November 6, 2023

Neuromodulation beyond itch is blocked by targeting IL-13Rα1 with eblasakimab

Yannick Miron, Paul Miller, Carl Firth, Ferda Cevikbas
Oral presentation at World Congress of Itch, 6 Nov 2023

Our Pipeline

Eblasakimab

Eblasakimab

Eblasakimab is a novel, fully human, monoclonal IgG4 antibody that binds specifically to the Interleukin (IL)-13 receptor, preventing signaling of IL-4 and IL-13 through the Type 2 receptor. Eblasakimab is currently being developed as a treatment for moderate-to-severe atopic dermatitis (AD).

Learn More

Farudodstat

Farudodstat is an orally active, potent inhibitor of the enzyme dihydroorotate dehydrogenase (DHODH), that suppresses T cell proliferation and secretion of Interferon Gamma (IFNγ) by blocking de novo production of pyrimidines required for DNA replication.

Learn More
Farudodstat
Aslan Pharmaceuticals Team

About Us

ASLAN Pharmaceuticals (Nasdaq: ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients.

Learn More